Allergan launches INSPIRA® as part of the NATRELLE® Collection of breast implants

Canadian surgeons now have even more options in implant shape, size, profile & texture to provide women with results that are tailored to their individual body types and surgical goals

MARKHAM, ON, Nov. 24, 2011 /CNW/ - On the five-year anniversary of the approval of silicone gel-filled breast implants in Canada, Allergan Inc. today introduced INSPIRA® -- a line of next generation round gel-filled breast implants that provides Canadian surgeons with even greater choice.  The INSPIRA® range was developed to address surgeons' need for additional innovative breast implant products that offer a customized fit and natural looking results in terms of shape, size, texture and projection (or profile) to complement a woman's unique body.

"The INSPIRA® range speaks to Allergan's commitment to science-based innovation in the medical aesthetics category," says Stu Fowler, President & General Manager, Allergan Canada. "Allergan has been a leader in this space for over two decades and we continue to assess, as well as respond to the needs of plastic surgeons using our products, and the needs of Canadian women interested in breast augmentation."

Recent findings from the National Plastic Surgery Survey of 300 Canadian women, between the ages of 22 and 59, suggest that 87 per cent of women would like to change at least one part of their body.1  Of the parts identified, breasts are the second leading feature that women would like to change after the stomach.2  In fact, 13 per cent of Canadian women have considered or are currently considering breast implant surgery, with women between the ages of 22 and 34 being seven times more likely to entertain the option of the procedure as compared to their older counterparts.3

According to the American Society of Plastic Surgeons, breast augmentation is the number one requested plastic surgery procedure in the United States.4  In addition, the American Society of Aesthetic Plastic Surgery estimates that breast augmentation accounts for roughly 20 per cent of all cosmetic surgical procedures performed in the United States with over 60 per cent of these using gel-filled implants.5

"Breast augmentation surgery has grown in popularity since silicone gel-filled breast implants first came to market in Canada," says Dr. Julie Khanna, one of Canada's leading cosmetic plastic surgeons and author of the book, Timeless Beauty.  "Surgeons are  looking for implant options that provide the best, individualized custom fit for their patients.  A woman's relationship with her breasts is quite personal, so options like the INSPIRA® range are an important development for plastic surgeons today because they allow us to offer a more natural looking, tailored result."

The INSPIRA® range offers over 300 next generation round, smooth and textured breast implant options, and has been available to patients outside Canada since 2006.6,7

According to the National Plastic Surgery Survey, Canadian women cite improvement in self-esteem (34 per cent) as one of the key motivating factors to undergo a plastic surgery procedure.8 Forty-eight per cent say that whether the surgery will look natural impacts their decision to pursue the procedure.9

Silicone gel-filled breast implants were approved for use in breast augmentation, reconstruction and revision surgery in Canada in 2006.10 Following this milestone, Allergan launched the NATRELLE® Collection in 2007 as the country's first recognizable brand name for Allergan's wide range of high-quality gel-filled and saline-filled breast implants for Canadian women seeking this type of surgery.

Women looking for more information about the NATRELLE® Collection and INSPIRA® range or to find a qualified, board-certified plastic surgeon are encouraged to visit

The National Plastic Surgery Survey was conducted by OnResearch Inc. and sponsored by Allergan Inc. The survey was completed online from May 10, 2011 to May 13, 2011 using an online panel with a random sample of 300 women between the ages of 22 years and 59 years.  A probability sample of the same size would yield a margin of error of + 5.7% at a 95 per cent confidence level.11

For more than 25 years, NATRELLE® gel-filled and saline breast implants have been available to women in more than 60 countries for breast augmentation, revision and reconstructive surgery.  Where both options are widely available, approximately 90 per cent of women choose silicone gel-filled over saline-filled breast implants.12

The NATRELLE® Collection offers women a wide range of effective, high-quality breast implant options.  From saline and gel-filled, to smooth and textured surfaces and varying shapes, to low, moderate and high profile (projection), a range of volumes, and degrees of silicone cohesivity, women today have more options than ever before in breast aesthetics.  The NATRELLE® Collection includes over 80 different saline breast implant options and over 500 gel-filled implant options in smooth, textured, round and anatomical styles.13

Breast implants are among the most studied medical devices in existence with more than 3,000 peer-reviewed and published studies, including 30 published epidemiological studies supporting their safe use.14  The safety of Allergan's NATRELLE® Collection breast implants is supported by the company's extensive pre-clinical device testing, the use of breast implants in millions of women worldwide over the past 25 years, and nearly a decade of U.S. clinical studies involving more than 150,000 women with either silicone gel-filled or saline-filled breast implants who have been followed for a total of over 214,000 person-years.15  Complete information about the NATRELLE® Collection can be found online at

Allergan is a multi-specialty health care company established more than 60 years ago with a commitment to uncover the best of science and to develop and deliver innovative and meaningful treatments to help people reach their life's potential.  Today, we have approximately 10,000 highly dedicated and talented employees, global marketing and sales capabilities with a presence in more than 100 countries, a rich and ever-evolving portfolio of pharmaceuticals, biologics, medical devices and over-the-counter consumer products, and state-of-the-art resources in R&D, manufacturing and safety surveillance that help millions of patients see more clearly, move more freely and express themselves more fully.  In Canada, Allergan employs close to 200 people and has a corporate head office in Markham, Ontario.

As a world leader in the medical aesthetics industry, Allergan is committed to the Science of Rejuvenation through its broad product portfolio, which includes BOTOX Cosmetic®, JUVÉDERM™ and LATISSE® available in Canada.  We are also committed to providing the highest quality education to women considering breast aesthetic surgery, so that they, along with their surgeons, can make an informed and educated decision about what is right for them.  Looking ahead, Allergan continues to lead science-based innovation in the area of breast aesthetics by offering women and their surgeons more options with additions to our extensive collection of high-quality breast implant devices.


  1. OnResearch Inc., Consumer Attitudes PR Study (National Plastic Surgery Survey): Report Version 2, dated May 19, 2011 pg. 9
  2. Consumer Attitudes PR Study (National Plastic Surgery Survey), pg. 9
  3. Consumer Attitudes PR Study (National Plastic Surgery Survey), pg. 12
  4. American Society of Plastic Surgery (ASPS), 2010 Top Five Cosmetic Surgical Procedures.  Available online at Last accessed September 6, 2011
  5. American Society of Aesthetic Plastic Surgery (ASAPS), Cosmetic Surgery National Data Banks Statistics:  Twenty 10 (pg. 5).  Available online at Last accessed September 6, 2011
  6. Allergan data on file
  7. Spear, SL and Hedén, P.  Review: Allergan's silicone gel breast implants. Expert Review of Medical Devices. September 2007, 4(5): 699-708.
  8. Consumer Attitudes PR Study (National Plastic Surgery Survey), pg. 15
  9. Consumer Attitudes PR Study (National Plastic Surgery Survey), pg. 16
  10. Allergan data on file
  11. Consumer Attitudes PR Study (National Plastic Surgery Survey), pg. 3
  12. Allergan data on file
  13. Allergan data on file
  14. Allergan data on file
  15. Allergan data on file

SOURCE Allergan

For further information:

Naziah Lasi-Tejani
Allergan Canada
T: +1 (905) 940-7178  

Morgan Cates 
Environics Communications
T: +1 (416) 969-2789


Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

CNW Membership

Fill out a CNW membership form or contact us at 1 (877) 269-7890

Learn about CNW services

Request more information about CNW products and services or call us at 1 (877) 269-7890